Technology & Innovation
Beyond the Standard Formulation.
A nutrient that is not absorbed is a cost, not a benefit. Fat-soluble actives pass through undissolved. Sensitive compounds degrade before they are absorbed. Effective doses become tablets that consumers will not take. Our delivery platforms exist to solve these problems — and each one is already running in commercial production.
Talk to Our R&D Team See the PlatformsFour platforms. One question behind each: how does it actually get absorbed?
Each platform below is running in commercial production today — not a lab concept, a formulation capability you can brief us on this week.
Nano-Emulsion Technology
Fat-soluble actives are reduced to nanoscale droplets and stabilised so they disperse in water rather than separating — allowing efficient uptake without oil-heavy carriers, in formats as light as a gummy.
Commercial productionLiposomal Systems
Actives are enclosed within a phospholipid layer that protects them through the digestive tract and supports absorption — particularly valuable for nutrients that are poorly tolerated or easily degraded.
Commercial productionDual-Action Dosing
A tablet and a softgel delivered as a single daily dose, allowing two release profiles and two ingredient chemistries in one product without compromising either.
Commercial productionMulti-Tablet Compression
Three separately engineered tablets contained within a single capsule: different actives, different release behaviour, one dose for the consumer.
Commercial productionBring us the molecule. We will tell you how to deliver it.
If you have an active that is difficult to absorb, unstable, unpalatable or awkward to dose, that is precisely the problem our formulation team is built to solve.
Talk to our R&D team →